SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001213900-23-015844
Filing Date
2023-03-01
Accepted
2023-03-01 07:22:23
Documents
1
Effectiveness Date
2023-03-01

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 ea174455-s8pos_clarustherap.htm S-8 POS 26934
  Complete submission text file 0001213900-23-015844.txt   28073
Mailing Address 355 S. GRAND AVENUE, SUITE 1450 LOS ANGELES CA 90071
Business Address 355 S. GRAND AVENUE, SUITE 1450 LOS ANGELES CA 90071 (847) 562-4300
Clarus Therapeutics Holdings, Inc. (Filer) CIK: 0001817944 (see all company filings)

IRS No.: 851231852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-261245 | Film No.: 23689769
SIC: 2836 Biological Products, (No Diagnostic Substances)